[Hypobetalipoproteinemic effect of trans-2,10-dichloro-6-ethoxycarbonyl-12-methyldibenzo[d,g] [1,3]dioxocin (EGYT-1932, Crismel)].
D000818:Animals; D006571:Heterocyclic Compounds / Q000494:pharmacology*; D006937:Hypercholesterolemia / Q000097:blood; D000960:Hypolipidemic Agents; D008077:Lipoproteins, LDL / Q000097:blood*; D051381:Rats
D006571:Heterocyclic Compounds; D000960:Hypolipidemic Agents; D008077:Lipoproteins, LDL; C020876:Crismel
A transz 2,10-diklór-6-etoxikarbonil-12-metildibenzo [d,g] [1,3]) dioxocin (EGYT--1932, Crismel) hipobétalipoproteinémias hatásának vizsgálata.